nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Determinants and prognostic value of quality of life in patients with pancreatic ductal adenocarcinoma
|
Deng, Yang |
|
2018 |
92 |
C |
p. 20-32 |
artikel |
2 |
Germline BAP1-positive patients: the dilemmas of cancer surveillance and a proposed interdisciplinary consensus monitoring strategy
|
Star, Phoebe |
|
2018 |
92 |
C |
p. 48-53 |
artikel |
3 |
Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door
|
Verlingue, Loic |
|
2018 |
92 |
C |
p. 1-10 |
artikel |
4 |
Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study
|
Verver, D. |
|
2018 |
92 |
C |
p. 100-107 |
artikel |
5 |
Mapping the cancer patient information landscape: A comparative analysis of patient groups across Europe and North America
|
Lawler, Mark |
|
2018 |
92 |
C |
p. 88-95 |
artikel |
6 |
Olaratumab in soft tissue sarcoma – Current status and future perspectives
|
Antoniou, Georgios |
|
2018 |
92 |
C |
p. 33-39 |
artikel |
7 |
Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab
|
Ibrahim, Sajida |
|
2018 |
92 |
C |
p. 119-120 |
artikel |
8 |
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer—a randomised biomarker-driven clinical phase II AIO study
|
Vogel, Arndt |
|
2018 |
92 |
C |
p. 11-19 |
artikel |
9 |
Predictive factors of outcome in poorly differentiated thyroid carcinomas
|
de la Fouchardière, Christelle |
|
2018 |
92 |
C |
p. 40-47 |
artikel |
10 |
Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma
|
Park, Marn Joon |
|
2018 |
92 |
C |
p. 69-76 |
artikel |
11 |
Raman spectroscopy for assessment of bone resection margins in mandibulectomy for oral cavity squamous cell carcinoma
|
Barroso, Elisa M. |
|
2018 |
92 |
C |
p. 77-87 |
artikel |
12 |
Response to Letter to the Editor, ‘Pharmacokinetics partly explains the relationship between CEA level and survival of colorectal cancer patients treated with ramucirumab,’ by Ibrahim et al.
|
Yoshino, Takayuki |
|
2018 |
92 |
C |
p. 121-122 |
artikel |
13 |
The future of blood-based biomarkers for the early detection of breast cancer
|
Loke, Sau Yeen |
|
2018 |
92 |
C |
p. 54-68 |
artikel |
14 |
Trends in incidence of thick, thin and in situ melanoma in Europe
|
Sacchetto, L. |
|
2018 |
92 |
C |
p. 108-118 |
artikel |
15 |
When and how to use carboplatin in metastatic castration-resistant prostate cancer?
|
Omlin, A. |
|
2018 |
92 |
C |
p. 96-99 |
artikel |